Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 20.3B | 21.6B | 20.1B | 19.7B |
| Cost of revenue | 16.2B | 17.4B | 16.1B | 16.1B |
| Gross profit | 4.1B | 4.2B | 4.0B | 3.6B |
| Operating expense | ||||
| Research & development | 637M | 808M | 751M | 706M |
| Selling general and admin | 1.4B | 1.6B | 1.4B | 1.4B |
| Other operating expenses | -4M | -258M | -134M | 896M |
| Operating income | 2.0B | 2.1B | 2.0B | 529M |
| Non operating interest income | ||||
| Income | 51M | 27M | 45M | 19M |
| Expense | 502M | 514M | 548M | 488M |
| Other income expense | 374M | 385M | 381M | 368M |
| Pretax income | 2.0B | 2.0B | 1.9B | 428M |
| Tax provision | 333M | 449M | 371M | 253M |
| Net income | 1.6B | 1.6B | 1.5B | 175M |
| Basic EPS | 1.2 | 1.1 | 1.1 | 0.1 |
| Diluted EPS | 1.1 | 1.1 | 1.1 | 0.1 |
| Basic average shares | 1.3B | 1.3B | 1.3B | 1.3B |
| Diluted average shares | 1.4B | 1.3B | 1.3B | 1.3B |
| EBITDA | 3.5B | 3.7B | 3.5B | 2.0B |
| Net income from continuing op. | 1.6B | 1.6B | 1.5B | 175M |
| Minority interests | -90M | -78M | -63M | -64M |
| Preferred stock dividends | — | — | — | — |